Poseida Therapeutics, Inc. Deferred Revenue
Poseida Therapeutics, Inc. had Deferred Revenue of $8.90 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2023-11-09
- 2023-09-30: Deferred Revenue $8.90M.
- 2023-06-30: Deferred Revenue $8.90M.
| Period end | Deferred Revenue |
|---|---|
| 2023-09-30 | $8.90M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $8.90M 10-Q · filed 2023-08-08 |